Osmotic therapy: fact and fiction
Related Experiment Video
Updated: Aug 15, 2026

Osmotic Pump-based Drug-delivery for In Vivo Remyelination Research on the Central Nervous System
Published on: December 17, 2021
Michael N Diringer1, Allyson R Zazulia
1Neurology/Neurosurgery Intensive Care Unit and Stroke Research Center, Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA. diringerm@wustl.edu
Abstract:
This review examines the available data on the use of osmotic agents in patients with head injury and ischemic stroke, summarizes the physiological effects of osmotic agents, and presents the leading hypotheses regarding the mechanism by which they reduce ICP. Finally, it addresses the validity of the following commonly held beliefs: mannitol accumulates in injured brain; mannitol shrinks only normal brain and can increase midline shift; osmolality can be used to monitor mannitol administration; mannitol should be not be administered if osmolality is >320 mOsm; and hypertonic saline is equally effective as mannitol.
Related Concept Videos
Osmosis
Osmosis
Water, like other substances, moves from a high concentration of free water...
Osmosis and Osmotic Pressure of Solutions
Osmotic Pressure
Tonicity in Animals
Tonicity in Animals
